Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Piebaldism × Clear all

Phase

Status

Completed 6 Unknown 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Breast Neoplasms 520 Neoplasms 398 Carcinoma, Non-Small-Cell Lung 308 Colorectal Neoplasms 284 Lung Neoplasms 232 Prostatic Neoplasms 211 Carcinoma, Hepatocellular 200 Stomach Neoplasms 157 Pancreatic Neoplasms 141 Multiple Myeloma 130 Leukemia, Myeloid, Acute 128 Uterine Cervical Neoplasms 126 Rectal Neoplasms 114 Recurrence 113 Squamous Cell Carcinoma of Head and Neck 102 Ovarian Neoplasms 102 Neoplasm Metastasis 97 Head and Neck Neoplasms 87 Triple Negative Breast Neoplasms 84 Glioblastoma 84 Esophageal Neoplasms 84 Brain Neoplasms 80 Small Cell Lung Carcinoma 79 Endometrial Neoplasms 79 Colonic Neoplasms 78 Melanoma 69 Precursor Cell Lymphoblastic Leukemia-Lymphoma 68 Glioma 65 Hematologic Neoplasms 64 Motor Activity 63

Interventions

Mastectomy, Segmental 1 Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05970900 2023-08-01

PIRKER

Fujian Medical University Union Hospital

Phase 3 Not yet recruiting

GastrointestinalSarcoma

Piebaldism, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡